Figure 3
From: Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort
Serological elastin neo-epitope biomarker levels in survivors (n = 970) and non-survivors (n = 30). ELP-3 was significantly elevated in non-survivors compared to survivors. Data were analyzed using Mann-Whitney test and presented as a Tukey box plot. Asterisks indicate statistical significance *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
